Pillstats
Rx only · Tablet, Film Coated · Oral

Suzetrigine

Brands: Journavx · Suzetrigine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)2704819
US makers2 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.43$8.86$13.29$17.72Dec 2025May 2026Jul 2026
$15.413
Latest avg · Jul 1, 2026
+4%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.0K12K18K24K2025 Q12025 Q22025 Q32025 Q42026 Q1
21K
Rx · 2026 Q1
556K
Units dispensed
+5385%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Vertex Pharmaceuticals Incorporatedunknown4SUPPLYING
Sportpharm LLCunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.